AAAAAA
Results:
1-16
|
Results: 16
Authors:
Heidland, A
Gerabek, W
Sebekova, K
Citation: A. Heidland et al., Franz Volhard and Theodor Fahr: achievements and controversies in their research in renal disease and hypertension, J HUM HYPER, 15(1), 2001, pp. 5-16
Authors:
Xiang, GS
Schinzel, R
Simm, A
Munch, G
Sebekova, K
Kasper, M
Niwa, T
Schmitz, C
Heidland, A
Citation: Gs. Xiang et al., Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 issuppressed by a protease in the tubule cell line LLC-PK1, NEPH DIAL T, 16(8), 2001, pp. 1562-1569
Authors:
Heidland, A
Sebekova, K
Schinzel, R
Citation: A. Heidland et al., Advanced glycation end products and the progressive course of renal disease, AM J KIDNEY, 38(4), 2001, pp. S100-S106
Authors:
Xiang, GS
Schinzel, R
Simm, A
Sebekova, K
Heidland, A
Citation: Gs. Xiang et al., Advanced glycation end products impair protein turnover in LLC-PK1: Amelioration by trypsin, KIDNEY INT, 59, 2001, pp. S53-S57
Authors:
Sebekova, K
Blazicek, P
Syrova, D
Krivosikova, Z
Spustova, V
Heidland, A
Schinzel, R
Citation: K. Sebekova et al., Circulating advanced glycation end product levels in rats rapidly increasewith acute renal failure, KIDNEY INT, 59, 2001, pp. S58-S62
Authors:
Krivosikova, Z
Dusinska, M
Spustova, V
Sebekova, K
Blazicek, P
Heidland, A
Dzurik, R
Citation: Z. Krivosikova et al., DNA damage of lymphocytes in experimental chronic renal failure: Beneficial effects of losartan, KIDNEY INT, 59, 2001, pp. S212-S215
Authors:
Schinzel, R
Munch, G
Heidland, A
Sebekova, K
Citation: R. Schinzel et al., Advanced glycation end products in end-stage renal disease and their removal, NEPHRON, 87(4), 2001, pp. 295-303
Authors:
Gajdos, M
Krivosikova, Z
Sebekova, K
Lajdova, I
Spustova, V
Dzurik, R
Citation: M. Gajdos et al., Enalapril inhibits growth and proliferation of various tissues in rat normotensive four-sixths kidney ablation nephropathy, KIDNEY BL P, 23(2), 2000, pp. 106-112
Authors:
Bahner, U
Sebekova, K
Heidland, A
Citation: U. Bahner et al., Chronic metabolic acidosis - are the clinical consequences underestimated?, NIEREN HOCH, 29(2), 2000, pp. 71-80
Authors:
Sebekova, K
Heidland, A
Waidheim, A
Schinzel, R
Citation: K. Sebekova et al., Evidence for accumulation of advanced glycation end products in acute renal failure, NEPHRON, 86(2), 2000, pp. 186-187
Authors:
Huang, SM
Schaefer, RM
Reisch, S
Paczek, L
Schaefer, L
Teschner, M
Sebekova, K
Heidland, A
Citation: Sm. Huang et al., Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis, KIDNEY BL P, 22(3), 1999, pp. 121-127
Authors:
Krivosikova, Z
Sebekova, K
Spustova, V
Lajdova, I
Dzurik, R
Citation: Z. Krivosikova et al., Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat, PHYSL RES, 48(6), 1999, pp. 429-435
Authors:
Sebekova, K
Schinzel, R
Munch, G
Krivosikova, Z
Dzurik, R
Heidland, A
Citation: K. Sebekova et al., Advanced glycation end-product levels in subtotally nephrectomized rats: Beneficial effects of angiotensin II receptor 1 antagonist losartan, MIN ELECT M, 25(4-6), 1999, pp. 380-383
Authors:
Sebekova, K
Dammrich, J
Krivosikova, Z
Heidland, A
Citation: K. Sebekova et al., The effect of oral protease administration in the rat remnant kidney model, RES EXP MED, 199(3), 1999, pp. 177-188
Authors:
Krivosikova, Z
Dusinska, M
Sebekova, K
Spustova, V
Heidland, A
Dzurik, R
Citation: Z. Krivosikova et al., DNA damage in lymphocytes in experimental chronic renal failure-beneficialeffects of losartan, NEOPLASMA, 46, 1999, pp. 86-87
Authors:
Sebekova, K
Dammrich, J
Fierlbeck, W
Krivosikova, Z
Paczak, L
Heidland, A
Citation: K. Sebekova et al., Effect of chronic therapy with proteolytic enzymes on hypertension-inducedrenal injury in the rat model of Goldblatt hypertension, AM J NEPHR, 18(6), 1998, pp. 570-576
Risultati:
1-16
|